The concept of essential medicines: lessons for rich countries.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

59 citing papers in PubMed.

1. Fortifying essential medicines supply chains in Sub-Saharan Africa - the curious cases of Kenya and Uganda.Global health action · 2026
   Review
2. [Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina].Revista panamericana de salud publica = Pan American journal of public health · 2026
   Article
3. The Political Economy of the World Health Organization Model Lists of Essential Medicines.The Milbank quarterly · 2025
   Article
4. Trends and disparity in the provision and consumption of essential medicines in China from 2016 to 2021: institutional, regional, and economic variations.Frontiers in public health · 2025
   Article
5. Uptake of orphan drugs in the WHO essential medicines lists.Bulletin of the World Health Organization · 2024
   Article
6. Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades.Journal of pharmaceutical policy and practice · 2023
   Article
7. Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.BMC health services research · 2022
   Article
8. Users' perceptions of the "My Medicine" mobile app usability.Journal of public health research · 2022
   Article
9. Proposal for Handling of Medicine Shortages Based on a Comparison of Retrospective Risk Analysis.International journal of environmental research and public health · 2022
   Review
10. National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis.PLoS medicine · 2022
    Review
11. A comprehensive analysis of selected medicines collected from private drug outlets of Dhaka city, Bangladesh in a simple random survey.Scientific reports · 2022
    Article
12. The Consistency Between the Chinese Essential Medicines List and Treatment Guidelines-Taking Oncology Medicines as an Example.Frontiers in public health · 2022
    Article
13. Pharmacoeconomics in Africa: needs, prospect and challenges.Journal of pharmaceutical policy and practice · 2021
    Article
14. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists.BMJ global health · 2020
    Article
15. The "Square Box": Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines.Frontiers in pharmacology · 2020
    Article
16. Prescribing patterns of antimicrobials in the Internal Medicine Department of Ibrahim Malik Teaching Hospital in Khartoum, 2016.The Pan African medical journal · 2019
    Article
17. Prevalence and Predictors of Statin Treatment Among Patients With Chronic Heart Failure at a Tertiary-Care Center in Thailand.Clinical Medicine Insights. Cardiology · 2019
    Article
18. Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?Antibiotics (Basel, Switzerland) · 2018
    Article
19. Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications.Frontiers in pharmacology · 2018
    Article
20. Country and regional variations in purchase prices for essential cancer medications.BMC cancer · 2017
    Article

Corrections and comments

• Commented on by
  The pros and cons of essential medicines for rich countries.2004
• Commented on by
  Learning from low income countries: poor patients deserve more science and less advocacy.2005

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as